Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Crofelemer

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,826Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Starts Phase 2 Trial of Crofelemer for Pediatric MVID
    Jaguar Starts Phase 2 Trial of Crofelemer for Pediatric MVID

    20 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/first-patient-randomized-in-jaguar-healths-phase-2-randomized-double-1029830

    ACCESSWIRE
    20 May 2025
    Share Share
    Jaguar Health Provides Overview of Crofelemer-Related Catalysts
    Jaguar Health Provides Overview of Crofelemer-Related Catalysts

    07 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-provides-overview-of-2025-crofelemer-related-catalysts-1024559

    ACCESSWIRE
    07 May 2025
    Share Share
    Crofelemer Shows Benefit in Rare Bowel Disorders
    Crofelemer Shows Benefit in Rare Bowel Disorders

    30 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/proof-of-concept-results-show-crofelemer-reduced-total-parenteral-nut-1021550

    ACCESSWIRE
    30 Apr 2025
    Share Share
    Jaguar to Share Crofelemer Study Data in April 30 Webcast
    Jaguar to Share Crofelemer Study Data in April 30 Webcast

    29 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/reminder-jaguar-health-hosting-april-30-investor-webcast-to-present-i-1021431

    ACCESSWIRE
    29 Apr 2025
    Share Share
    Jaguar Health to Present Initial Results from Crofelemer Study
    Jaguar Health to Present Initial Results from Crofelemer Study

    28 Apr 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-to-present-initial-results-from-the-proof-of-concept-st-1020349

    ACCESSWIRE
    28 Apr 2025
    Share Share
    Jaguar Health Meets FDA on Phase 3 OnTarget Study Results
    Jaguar Health Meets FDA on Phase 3 OnTarget Study Results

    27 Mar 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-meeting-with-fda-regarding-results-of-phase-3-ontarget-1005216

    ACCESSWIRE
    27 Mar 2025
    Share Share